Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo
São Paulo, 05403-900, Brazil
NCT Number: NCT07207525
Pulmonary hypertension is a serious disease that affects patients' health, daily life, and emotional well-being. Many patients and their caregivers actively look for information to better understand the condition and its treatment. However, the quality of information found in different sources, such as the internet, social media, health professionals, and patient groups, can vary.
This study will use a short questionnaire to learn where patients and caregivers search for information, what topics they look for, how satisfied they are with what they find, and which sources they trust most. The results will help improve communication strategies, educational materials, and support programs for people living with pulmonary hypertension and their families.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
São Paulo, 05403-900, Brazil
Pulmonary hypertension (PH) is a chronic and progressive disease often diagnosed late, which forces patients and caregivers to actively seek information to understand and manage the condition. The complexity of PH, combined with its physical, emotional, and social impact, makes access to reliable health information essential.
This cross-sectional observational study will apply a structured, self-administered questionnaire to approximately 200 participants (100 patients with confirmed PH and 100 informal caregivers). The questionnaire covers demographic and clinical characteristics, information sources used, expectations and satisfaction, most frequently searched topics, experiences with conflicting information, and preferred communication channels.
The goal is to describe patterns of health information seeking in this population and identify opportunities to improve communication, educational resources, and patient-caregiver support. Findings are expected to contribute to the development of more effective health communication strategies and to guide health professionals in addressing information needs in pulmonary hypertension.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 12 months after study start
Identification of the primary sources of information used by patients with pulmonary hypertension and their informal caregivers, as reported in the structured questionnaire.
Time frame: Up to 12 months after study start
Level of satisfaction with the health information found, measured on a 5-point Likert scale (1 = not satisfied, 5 = very satisfied).
Time frame: Up to 12 months after study start
Degree of confidence when searching for information, measured on a 5-point Likert scale (1 = not confident, 5 = very confident).
Time frame: Up to 12 months after study start
Proportion of participants reporting that they found contradictory or inconsistent health information related to pulmonary hypertension.
Time frame: Up to 12 months after study start
Distribution of the main topics searched (e.g., treatments, prognosis, daily care, rights/benefits) as reported in the questionnaire.
Time frame: Up to 12 months after study start
Identification of the channels considered most reliable for health information (e.g., physician, healthcare team, patient groups, internet sources).
Contact information is provided by the study sponsor or research team.
University of Sao Paulo General Hospital
Other
Sources of Information and Search Patterns on Pulmonary Hypertension in Patients With Confirmed Diagnosis and Their Caregivers (inPHorma)
Acronym: inPHorma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07172334
Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Bordeaux, France
View Trial DetailsNCT07667829
Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Beijing, Beijing Municipality, China
View Trial DetailsNCT07487441
Cardiovascular Diseases, Hypertension
Tucson, Arizona, United States
View Trial DetailsNCT07318597
Cardiovascular Diseases, Hypertension
Aurora, Colorado, United States
View Trial Details